Elmiron

cityscape

Pharma

NICE backs old bladder pain drug Elmiron despite 'uncertainty'

Due to "substantial uncertainty" over its clinical evidence, NICE is only covering Elmiron when other oral drugs fail.

Angus Liu Oct 10, 2019 11:50am

fda

FDA rolls out hit list of brands that lack copycat rivals

Jun 27, 2017 11:01am